Prenatal use of medications for gastroesophageal reflux disease and early childhood fracture risk.
Heather L WolfeJared A WolfeAnju RanjitAmanda BanaagTracey Pérez KoehlmoosCatherine T WitkopPublished in: Birth (Berkeley, Calif.) (2019)
We found no increase in early childhood fracture risk with maternal antireflux medication use. This suggests that prenatal exposure to antireflux medications does not affect fetal bones to a clinically significant extent.